Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 447 (RNA5SP447) is a non-coding processed pseudogene found in the human genome. Processed pseudogenes such as RNA5SP447 are typically generated by retrotransposition of mRNA transcripts from functional genes; they lack introns, canonical regulatory elements, and coding capacity due to disabling mutations or deletions[4][6]. RNA5SP447 does not encode a functional RNA or protein and is not a biologically active molecule in translation or any other cellular process; instead, it is an inactive genomic sequence that shares high sequence homology with the parental 5S ribosomal RNA gene but lacks its biological function and transcriptional activity[2][4][5]. The functional 5S rRNA, from which this pseudogene derives, acts as a structural component in the large subunit of ribosomes, facilitating assembly and functional communication within the ribosome[1][3][7]. However, pseudogenes like RNA5SP447 do not play any known role in cellular biology, disease pathogenesis, or as therapeutic targets. RNA5SP447 is classified as an rRNA pseudogene, specifically a processed pseudogene, according to gene annotation standards[6]. Processed pseudogenes are typically transcriptionally silent and do not encode functional products[4][6]. Unlike functional 5S rRNA, pseudogenes do not participate in ribosomal structure or function. While a minority of pseudogenes have been reported to modulate gene expression through RNA mechanisms in some contexts, there is no evidence that RNA5SP447 has such a role. It is not implicated in any human disease nor used as a biomarker[4]. It is not considered a therapeutic target, drug target, or functional molecule for pharmacology or diagnostics[5][2]. The term “RNA, 5S ribosomal pseudogene 447” refers specifically to a processed pseudogene and not to a functional molecule, target, or receptor. It should not be considered a pharmacologically relevant target; inclusion as a therapeutic target would be incorrect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 447 (RNA5SP447).